What we doState-of-the-art biotechnology
centered on antibody engineering

Areas of focus

Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company, contributing to
human health and well-being worldwide through innovative drug discovery and
global commercialization, driven by state-of-the-art antibody technologies,
in the core therapeutic areas of oncology, nephrology,
central nervous system and immunology.

Cutting-edge biotechnology
centered on antibody
engineering technology

Nephrology Nephrology
Immunology & Allergy Immunology & Allergy
Oncology Oncology
Central Nervous System Central Nervous System

Technology-driven drug discovery

The novel drug discovery of Kyowa Kirin is firmly
supported by the exquisite experience and
technologies in research, development and
manufacture of biologics, and by open
innovation.
This unique style of drug discovery is
what we call technology-driven drug discovery,
focused
on 4 key modalities below.

Main products

Pipeline

Numerous promising pharmaceutical
candidates are emerging from our
development
pipelines the result of our
never-ending efforts to hone the edge of our
state-of-the-art
technologies anddeliver
innovation in medical care.

Partnerships

We are open and flexible to strategic collaborations
and partnerships
with pharmaceuticals, biotech,
and academia partners.

ADARE pharmaceuticals™ aevi genomic medicine™ Alcon Pharma Alnylam PHARMACEUTICALS AMGEN ARDELYX argenx Argos THERAPEUTICS ARQULE<sup>®</sup> astellas Leading Light for Life AstraZeneca Medlmmune AVEO ONCOLOGY Biogen Bristol-Myers Squibb BRITANNIA PHARMACEUTICALS LTD Cantergia CHUGAI Roche A member of the Roche group Daiichi-Sankyo Eisai FERRING PHARMACEUTICALS FivePrime FUJIFILM Genentech IN BUSINESS FOR LIFE genzyme A SANOFI COMPANY GlaxoSmithKline Hisamitsu IDC Theranostics Immunas Pharma inibsa HOSPITAL janssen Jazz Pharmaceuticals JB Japan Blood Products Organization JCR Pharmaceuticals Co., Ltd. KALOBIOS Better Life Through Better Life Science LEO Lonza meiji Mitsubishi Tanabe pharma Novartis ONO ONO PHARMACEUTICAL CO.,LTD. orexo Otsuka OXFORD BioTherapeutics Phzer Pierre Fabre REATA REGiMMUNE Sandoz SERVIER Shire-Nps Pharmaceuticals Solasia Syndax Takeda TERUMO ZERIA GROUP TILLOTTS PHARMA GI-health is our passion™ TOYOCHEM ultragenyx pharmaceutical Yakult ゼリア新薬 ZERIA ADARE pharmaceuticals™ aevi genomic medicine™ Alcon Pharma Alnylam PHARMACEUTICALS AMGEN ARDELYX argenx Argos THERAPEUTICS ARQULE<sup>®</sup> astellas Leading Light for Life AstraZeneca Medlmmune AVEO ONCOLOGY Biogen Bristol-Myers Squibb BRITANNIA PHARMACEUTICALS LTD Cantergia CHUGAI Roche A member of the Roche group Daiichi-Sankyo Eisai FERRING PHARMACEUTICALS FivePrime FUJIFILM Genentech IN BUSINESS FOR LIFE genzyme A SANOFI COMPANY GlaxoSmithKline Hisamitsu IDC Theranostics Immunas Pharma inibsa HOSPITAL janssen Jazz Pharmaceuticals JB Japan Blood Products Organization JCR Pharmaceuticals Co., Ltd. KALOBIOS Better Life Through Better Life Science LEO Lonza meiji Mitsubishi Tanabe pharma Novartis ONO ONO PHARMACEUTICAL CO.,LTD. orexo Otsuka OXFORD BioTherapeutics Phzer Pierre Fabre REATA REGiMMUNE Sandoz SERVIER Shire-Nps Pharmaceuticals Solasia Syndax Takeda TERUMO ZERIA GROUP TILLOTTS PHARMA GI-health is our passion™ TOYOCHEM ultragenyx pharmaceutical Yakult ゼリア新薬 ZERIA